CLINICAL_TRIALS
trial_result
· 2023-10-10
Clinical Trial Update: Positioning Imatinib for Pulmonary Arterial Hypertension [Phase 2]
Summary
Phase 2 clinical trial exploring imatinib for pulmonary arterial hypertension is in early stages with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imperial College London | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: UNKNOWN